Antibiotics for Skin Infections
First-Line Oral Therapy for Uncomplicated Infections
For mild, non-purulent skin infections (cellulitis), use cephalexin 500 mg every 6 hours, dicloxacillin 250-500 mg every 6 hours, or amoxicillin-clavulanate 875/125 mg twice daily as first-line therapy. 1, 2, 3 These agents provide excellent coverage against streptococci and methicillin-sensitive Staphylococcus aureus (MSSA), the most common pathogens in uncomplicated skin infections. 1, 4
When to Add MRSA Coverage
Add empiric MRSA-active antibiotics if any of the following are present: 2
- Purulent drainage from the wound
- Penetrating trauma or injection drug use
- Evidence of MRSA infection elsewhere on the body
- Known nasal MRSA colonization
- Failed initial beta-lactam therapy
For MRSA coverage, use trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily, doxycycline 100 mg twice daily, or clindamycin 300-450 mg four times daily. 1, 2, 3 These oral agents are highly effective against community-acquired MRSA while maintaining activity against streptococci. 1, 4
Purulent Infections (Abscesses, Furuncles)
Incision and drainage is the primary treatment for purulent infections, with antibiotics serving as adjunctive therapy only. 2 Antibiotics are specifically indicated when: 2
- Fever or systemic signs are present
- Multiple lesions exist
- The patient is immunocompromised
- Drainage alone has failed
Use the same MRSA-active oral regimens listed above (trimethoprim-sulfamethoxazole, doxycycline, or clindamycin) for 5 days if clinical improvement occurs. 1, 2
Severe Infections Requiring Hospitalization
For severe infections with systemic inflammatory response syndrome, hemodynamic instability, or concern for necrotizing infection, initiate IV vancomycin 15-20 mg/kg every 8-12 hours plus piperacillin-tazobactam 3.375 g every 6 hours or a carbapenem (imipenem 500 mg every 6 hours or meropenem 1 g every 8 hours). 1, 5 This broad-spectrum regimen covers MRSA, streptococci, gram-negative organisms, and anaerobes. 1, 5
Alternative IV Regimens by Clinical Scenario
For surgical site infections of trunk/extremity (away from axilla/perineum): 1
- Cefazolin 1 g every 8 hours IV (for MSSA/streptococci)
- Add vancomycin 15 mg/kg every 12 hours if MRSA suspected
For necrotizing fasciitis: 1
- Clindamycin 600-900 mg IV every 8 hours plus piperacillin-tazobactam 4.5 g every 8 hours, with or without vancomycin 1
- Alternative: Ceftriaxone 1 g every 24 hours plus metronidazole 500 mg every 8 hours, with or without vancomycin 1
- For documented group A streptococcal necrotizing fasciitis, use penicillin plus clindamycin 1
Treatment Duration
Treat for 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 1, 2 For diabetic foot infections, mild cases require 1-2 weeks while moderate-to-severe infections need 2-4 weeks. 5
Special Situations
Diabetic Foot Infections
For mild infections: 1
- Dicloxacillin, clindamycin, cephalexin, levofloxacin, amoxicillin-clavulanate, or doxycycline
- Add trimethoprim-sulfamethoxazole if MRSA confirmed
For moderate-to-severe infections: 1
- Levofloxacin 750 mg daily, ertapenem 1 g daily, or ampicillin-sulbactam 3 g every 6 hours
- Add vancomycin, linezolid, or daptomycin if MRSA confirmed
Bite Wounds
Use amoxicillin-clavulanate 875/125 mg twice daily orally or ampicillin-sulbactam 1.5-3 g every 6-8 hours IV for animal or human bites. 2, 3 These agents provide essential coverage against both aerobic and anaerobic pathogens commonly found in bite wounds. 2
Recurrent Infections
For patients with 3-4 episodes per year despite treating predisposing factors: 1
- Prophylactic oral penicillin or erythromycin twice daily for 4-52 weeks, OR
- Intramuscular benzathine penicillin every 2-4 weeks
Consider decolonization with intranasal mupirocin twice daily for 5 days plus daily chlorhexidine washes. 2
Critical Pitfalls to Avoid
Do not add MRSA coverage reflexively for all hospitalized patients—MRSA is uncommon in typical cellulitis even in high-prevalence settings. 5 Reserve broad-spectrum therapy for documented severe infections or specific risk factors. 5
Never use clindamycin or metronidazole as monotherapy for mixed infections, as gram-negative coverage is essential. 5 For polymicrobial infections, combination therapy is mandatory. 5
Reassess treatment at 48 hours to verify clinical response, as treatment failure rates of 21% have been reported with some oral regimens. 5 Prompt surgical consultation is mandatory for necrotizing infections, as antibiotics alone are insufficient and mortality increases dramatically with delayed debridement. 1, 5